Last reviewed · How we verify

Anise-oil EC Capsule — Competitive Intelligence Brief

Anise-oil EC Capsule (Anise-oil EC Capsule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal carminative / digestive aid. Area: Gastroenterology.

phase 3 Herbal carminative / digestive aid Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Anise-oil EC Capsule (Anise-oil EC Capsule) — Shiraz University of Medical Sciences. Anise oil acts as a carminative and anti-inflammatory agent that reduces gastrointestinal distension and promotes digestive comfort through its volatile oil constituents.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Anise-oil EC Capsule TARGET Anise-oil EC Capsule Shiraz University of Medical Sciences phase 3 Herbal carminative / digestive aid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal carminative / digestive aid class)

  1. Shiraz University of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anise-oil EC Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/anise-oil-ec-capsule. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: